Wishpond Technologies announced that Jacky He will become the new Chief Financial Officer starting November 1, 2026, pending TSX Venture Exchange approval. He succeeds Adrian Lim, who is stepping down but will remain as an advisor. Jacky He has been with Wishpond since 2020 and has played a key role in financial reporting and planning. This leadership change aims to ensure continuity and strengthen Wishpond's financial management as it continues to grow its AI-enabled marketing solutions business.
The appointment of Jacky He as CFO at Wishpond provides context for readers interested in technology sector trends. For readers following technology stocks, here is Pluang's market snapshot as of Oct 21, 2026 03:11 WIB: Out of 150 priced US technology stocks, 108 rose and 40 fell today. Notable movers include EGHT (8x8 Inc) at USD 2.13 with a 1-day change of +6.50% and 100% sell order activity, UMC (United Microelectronics Corp) at USD 19.68 with a 1-day change of -5.90% and 86% sell order activity, and ASAN (Asana Inc.) at USD 10.74 with a 1-day change of +5.81% and 100% sell order activity. Typical hold times on Pluang range from 17 to 43 days for these stocks.
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
